two-woman-embrace
two-woman-embrace

Clinical Trials

Physicians and Patients

Physicians interested in learning more about MorphoSys-sponsored clinical trials should contact: medinfo@morphosys.com.
Patients are kindly asked to contact their treating physicians if they are interested in participating in any of MorphoSys' clinical trials.

Hero Tafa
Hero Tafa

TAFASITAMAB

Thank you for your interest in conducting a tafasitamab investigator-initiated trial. MorphoSys has partnered with Incyte on the development of tafasitamab. Incyte is managing the submission process.

Disclaimer
MorphoSys’ product candidates are investigational and are currently not approved for the treatment of any disease or condition anywhere in the world. They cannot be prescribed or purchased for therapy at present.

The MorphoSys website may contain information on drug candidates and clinical trials sponsored by MorphoSys with the intention of increasing the transparency of the company’s clinical research. There is no guarantee any product will be approved in the sought after indication.

Information contained within this website is not intended to replace the advice of a healthcare professional and should not be considered as a recommendation. Patients should always seek medical advice before making any decisions on their treatment.

All reasonable precautions have been taken to ensure the accuracy, security and confidentiality of information available through the site. MorphoSys may amend the information at any time without notice.